Despite delays of comprehensive medical reform, the UK government has now invested in a medical cannabis firm.
The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy…
Could GW Pharmaceuticals see the same success with Sativex that they now have with Epidiolex?
GW Pharmaceuticals has chosen the perfect moment to file its cannabis-derived therapy, Epidiolex, with U.S. regulators. The New England Journal of…
In June, the U.S. government lifted restrictions on scientific research into the medical and therapeutic benefits of marijuana, making biotech…
Last week, UK-based GW Pharmaceuticals acknowledged that its cannabis-based oral spray, Sativex, failed a late-stage clinical trial as the experimental…
The term CBD has been all over the media lately. Both Dr. Sanjay Gupta and the New York Times are…